Get started
Author

Shanshan Du

Overcoming immunotherapy resistance in extensive-stage small cell lung cancer: Insights into mechanisms and therapeutic opportunities
2026 · Ruonan Guan, Chenyue Zhang, et al. · Critical Reviews in Oncology/Hematology · 1
Spatial and maturational characterisation of tertiary lymphoid structures predicts immunotherapy response in extensive‐stage small cell lung cancer
2026 · Haoyu Wang, Xiaoling Shang, et al. · Clinical & Translational Immunology
PDF
The application of contrast-enhanced T2-FLAIR MRI in gross tumor target volume determination for radiotherapy of large-volume brain metastases
2026 · Shanshan Du, Yong Yin, et al. · Scientific Reports
PDF
Clarifying the role of flumonertinib rechallenge in EGFR-mutated non-small cell lung cancer
2026 · Haoyu Wang, Chenyue Zhang, et al. · Journal of Thoracic Disease
Flumonertinib after prior third-generation EGFR-tyrosine kinase inhibitor (TKI) therapy in patients with epidermal growth factor receptor-mutated non-small cell lung cancer after resistance to third-generation tyrosine kinase inhibitor treatment: a real-world study
2026 · Haoyu Wang, Chenyue Zhang, et al. · Journal of Thoracic Disease
Works count: 5
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type